Current Cardiology Reports

, Volume 10, Issue 4, pp 285–290 | Cite as

Lessons learned from the CRUSADE National Quality Improvement Initiative

  • Eric D. Peterson
  • David Z. Bynum
  • Matthew T. Roe
Article

Abstract

The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69–e171.PubMedCrossRefGoogle Scholar
  2. 2.
    Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002, 40:1366–1374.PubMedCrossRefGoogle Scholar
  3. 3.
    Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy [no authors listed]. N Engl J Med 1998, 339:436–443.CrossRefGoogle Scholar
  4. 4.
    Savonitto S, Ardissino D, Granger CB, et al.: Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999, 281:707–713.PubMedCrossRefGoogle Scholar
  5. 5.
    Bhatt DL, Topol EJ: Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 2000, 284:1549–1558.PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447–452.PubMedCrossRefGoogle Scholar
  7. 7.
    Antman EM, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999, 100:1593–1601.PubMedGoogle Scholar
  8. 8.
    Yusuf S, Zhao F, Mehta SR, et al.: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494–502.PubMedCrossRefGoogle Scholar
  9. 9.
    Cho L, Bhatt DL, Marso SP, et al.: An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. Am J Med 2003, 114:106–111.PubMedCrossRefGoogle Scholar
  10. 10.
    Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879–1887.PubMedCrossRefGoogle Scholar
  11. 11.
    Wallentin L, Lagerqvist B, Husted S, et al.: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000, 356:9–16.PubMedCrossRefGoogle Scholar
  12. 12.
    Anderson JL, Adams CD, Antman EM, et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1–e157.PubMedCrossRefGoogle Scholar
  13. 13.
    Peterson ED, Roe MT, Mulgund J, et al.: Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006, 295:1912–1920.PubMedCrossRefGoogle Scholar
  14. 14.
    Kandzari DE, Roe MT, Chen AY, et al.: Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2005, 149:474–481.PubMedCrossRefGoogle Scholar
  15. 15.
    Yusuf S, Zhao F, Mehta SR, et al.: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494–502PubMedCrossRefGoogle Scholar
  16. 16.
    Ferguson JJ, Califf RM, Antman EM, et al.: Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004, 292:45–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Jha P, Deboer D, Sykora K, Naylor CD: Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996, 27:1335–1342.PubMedCrossRefGoogle Scholar
  18. 18.
    Fox KA, Steg PG, Eagle KA, et al.: Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007, 297:1892–1900.PubMedCrossRefGoogle Scholar
  19. 19.
    Roe MT, Peterson ED, Newby LK, et al.: The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2006, 151:1205–1213.PubMedCrossRefGoogle Scholar
  20. 20.
    Alexander KP, Roe MT, Chen AY, et al.: Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005, 46:1479–1487.PubMedCrossRefGoogle Scholar
  21. 21.
    Skolnick AH, Alexander KP, Chen AY, et al.: Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol 2007, 49:1790–1797.PubMedCrossRefGoogle Scholar
  22. 22.
    Brogan GX Jr, Peterson ED, Mulgund J, et al.: Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care 2006, 29:9–14.PubMedCrossRefGoogle Scholar
  23. 23.
    Roe MT, Chen AY, Riba AL, et al.: Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2006, 97:1707–1712.PubMedCrossRefGoogle Scholar
  24. 24.
    Han JH, Chandra A, Mulgund J, et al.: Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med 2006, 119:248–254.PubMedCrossRefGoogle Scholar
  25. 25.
    Blomkalns AL, Chen AY, Hochman JS, et al.: Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005, 45:832–837.PubMedCrossRefGoogle Scholar
  26. 26.
    Sonel AF, Good CB, Mulgund J, et al.: Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 2005, 111:1225–1232.PubMedCrossRefGoogle Scholar
  27. 27.
    Calvin JE, Roe MT, Chen AY, et al.: Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2006, 145:739–748.PubMedGoogle Scholar
  28. 28.
    Alexander KP, Chen AY, Roe MT, et al.: Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005, 294:3108–3116.PubMedCrossRefGoogle Scholar
  29. 29.
    LaPointe NM, Chen AY, Alexander KP, et al.: Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. Arch Intern Med 2007, 167:1539–1544.PubMedCrossRefGoogle Scholar
  30. 30.
    Alexander KP, Chen AY, Newby LK, et al.: Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 2006, 114:1380–1387.PubMedCrossRefGoogle Scholar
  31. 31.
    Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators [no authors listed]. Lancet 1999, 354:708–715.CrossRefGoogle Scholar
  32. 32.
    Fox KA, Poole-Wilson PA, Henderson RA, et al.: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002, 360:743–751.PubMedCrossRefGoogle Scholar
  33. 33.
    Mehta SR, Cannon CP, Fox KA, et al.: Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005, 293:2908–2917.PubMedCrossRefGoogle Scholar
  34. 34.
    Bhatt DL, Roe MT, Peterson ED, et al.: Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004, 292:2096–2104.PubMedCrossRefGoogle Scholar
  35. 35.
    Mehta RH, Roe MT, Chen AY, et al.: Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006, 166:2027–2034.PubMedCrossRefGoogle Scholar
  36. 36.
    Tricoci P, Peterson ED, Mulgund J, et al.: Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). Am J Cardiol 2006, 98:1172–1176.PubMedCrossRefGoogle Scholar
  37. 37.
    Glickman SW, Ou FS, DeLong ER, et al.: Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA 2007, 297:2373–2380.PubMedCrossRefGoogle Scholar
  38. 38.
    Alexander KP, Chen AY, Roe MT, et al.: Decline in GP 2b3a Inhibitor Overdosing with Site-Specific Feedback in CRUSADE. Circulation 2007, 116(16 Suppl II):798–799.Google Scholar
  39. 39.
    Lytle BL, Fraulo ES, Mulgund J, et al.: What aspects of hospital culture influence quality? Crit Pathw Cardiol 2007, 6:145–149PubMedGoogle Scholar
  40. 40.
    Glickman SW, Boulding W, Staelin R, et al.: A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2007, 154:1206–1220.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  • Eric D. Peterson
    • 1
  • David Z. Bynum
  • Matthew T. Roe
  1. 1.Duke Clinical Research InstituteDurhamUSA

Personalised recommendations